Placebo oral rinse

OTHER6 trials

Sponsors

National Cancer Institute (NCI), The Forsyth Institute, GlaxoSmithKline, Sunstar Americas, Universidad de Granada

Conditions

Dentin SensitivityGingival InflammationOral Chronic Graft vs Host DiseasePeriodontitisXerostomia

Phase 1

Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis

CompletedNCT02342691

The Forsyth InstituteGingival Inflammation

Start: 2015-04-30End: 2019-08-30Updated: 2023-12-20

Phase 2

Clobetasol for Oral Graft-Versus-Host Disease

CompletedNCT01557517

National Cancer Institute (NCI)Oral Chronic Graft vs Host Disease

Start: 2012-03-28End: 2017-08-24Updated: 2025-06-15

Unknown Phase

Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity

CompletedNCT02542943

GlaxoSmithKlineDentin Sensitivity

Start: 2015-09-30End: 2015-12-31Updated: 2017-03-06

A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.

CompletedNCT02753075

GlaxoSmithKlineDentin Sensitivity

Start: 2015-09-08End: 2015-12-18Updated: 2018-08-27

Clinical Evaluation of Oral Rinse for Xerostomia

CompletedNCT04289051

Sunstar AmericasXerostomia

Start: 2020-08-19End: 2021-02-04Updated: 2022-02-24

Effect of Essential Oils as Adjutants on the Treatment of Subjects With Periodontitis: Assessment of Metabolic Variables as Effect Modifiers

TerminatedNCT04692246

Universidad de GranadaPeriodontitis

Start: 2019-11-01End: 2020-03-01Updated: 2020-12-31

Related Papers

Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation

Frontiers in Immunology2021-09-1372 citations

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Blood2016-12-021 citations